XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
Schedule of Segment Revenue and Operating Income
The following tables present financial information for each reportable segment (in millions):
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Revenues:
Surgical Facility Services$525.8 $361.0 $1,021.6 $784.2 
Ancillary Services17.5 13.2 34.1 30.2 
Optical Services— 0.5 — 1.3 
Total$543.3 $374.7 $1,055.7 $815.7 
Adjusted EBITDA:
Surgical Facility Services$95.6 $80.0 $190.6 $147.2 
Ancillary Services(0.1)(1.3)(1.0)(3.3)
Optical Services— 0.2 — 0.6 
All other(19.6)(20.7)(40.8)(39.8)
Total$75.9 $58.2 $148.8 $104.7 
Reconciliation of Adjusted EBITDA:
Income (loss) before income taxes$6.1 $(4.5)$17.1 $(28.1)
Net income attributable to non-controlling interests(35.7)(28.6)(67.5)(47.7)
Depreciation and amortization25.2 23.4 50.9 45.2 
Interest expense, net53.4 49.2 106.7 96.3 
Equity-based compensation expense4.1 3.4 9.3 6.9 
Transaction, integration and acquisition costs (1)
11.4 10.1 20.8 22.7 
Loss on disposals and deconsolidations, net1.0 2.9 0.1 6.4 
Litigation settlement and other litigation costs (2)
0.8 2.3 1.8 3.8 
Loss on debt extinguishment9.6 — 9.6 — 
Gain on escrow release (3)
— — — (0.8)
Adjusted EBITDA$75.9 $58.2 $148.8 $104.7 
(1)This amount includes transaction and integration costs of $9.2 million and $4.9 million for the three months ended June 30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million and $5.2 million for the three months ended June 30, 2021 and 2020, respectively.
This amount includes transaction and integration costs of $14.5 million and $10.4 million for the six months ended June 30, 2021 and 2020, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million and $12.3 million for the six months ended June 30, 2021 and 2020, respectively.
(2)This amount includes other litigation costs of $0.8 million and $2.3 million for the three months ended June 30, 2021 and 2020, respectively.
This amount includes other litigation costs of $1.8 million and $2.6 million for the six months ended June 30, 2021 and 2020, respectively. This amount includes litigation settlement costs of $1.2 million for the six months ended June 30, 2020, with no comparable costs in the 2021 period.
(3)Included in other income in the condensed consolidated statement of operations for the six months ended June 30, 2020.
Reconciliation of Assets from Segment to Consolidated
June 30,
2021
December 31,
2020
Assets:
Surgical Facility Services$5,021.6 $4,962.4 
Ancillary Services32.7 35.0 
All other566.3 415.8 
Total assets$5,620.6 $5,413.2 
Schedule of Financial Information by Reportable Segment
Six Months Ended June 30,
20212020
Cash purchases of property and equipment:
Surgical Facility Services$27.2 $16.8 
Ancillary Services0.2 0.1 
All other0.6 3.0 
Total cash purchases of property and equipment$28.0 $19.9